Showing 41 - 60 results of 168 for search '"Eye disease"', query time: 0.08s Refine Results
  1. 41

    Topical neurokinin-1 receptor antagonism ameliorates ocular pain and prevents corneal nerve degeneration in an animal model of dry eye disease by Amirreza Naderi, Yukako Taketani, Shudan Wang, Francesca Kahale, Ann Yung, Pier Luigi Surico, Yihe Chen, Reza Dana

    Published 2025-02-01
    “…Ocular pain is a common complaint to eye care providers, associated with a variety of ocular conditions, among which dry eye disease (DED) is affecting millions of people worldwide. …”
    Get full text
    Article
  2. 42

    Dry Eye Disease following Refractive Surgery: A 12-Month Follow-Up of SMILE versus FS-LASIK in High Myopia by Bingjie Wang, Rajeev K. Naidu, Renyuan Chu, Jinhui Dai, Xiaomei Qu, Hao Zhou

    Published 2015-01-01
    “…Purpose. To compare dry eye disease following SMILE versus FS-LASIK. Design. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47

    Saunders Ophthalmology Word Book / by Adams, Joyce

    Published 1991
    Subjects:
    View in OPAC
    Book
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52

    ‘It was like being hit with a brick’: a qualitative study on the effect of clinicians’ delivery of a diagnosis of eye disease for patients in primary and secondary care by Lucy Moore, Jasleen Kaur Jolly, Anne Ferrey

    Published 2022-07-01
    “…Objectives To explore patients’ experiences of getting a diagnosis of eye disease, the psychological impact of this and how this could be improved.Design An exploratory qualitative interview study using a narrative approach and inductive methods.Setting This study was conducted with patients who had attended ophthalmic appointments in primary and secondary care and in opticians located in the South of England.Participants 18 people diagnosed with eye disease in England.Results Four themes were identified: the convoluted process of being diagnosed, the impact of clinicians’ words, the search for information and reflections on what could be improved. …”
    Get full text
    Article
  13. 53

    Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics by Laura M. Periman, Darrell E. White, Douglas Katsev

    Published 2025-01-01
    “…Abstract Perfluorohexyloctane ophthalmic solution (Miebo) and water-free cyclosporine ophthalmic solution 0.1% (Vevye) are recently approved treatments for dry eye disease (DED). Perfluorohexyloctane (PFHO) uses a novel approach to treat evaporative DED, whereas water-free cyclosporine (CsA 0.1%) is formulated to increase ocular delivery of its active ingredient to improve tear production. …”
    Get full text
    Article
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60